The mRNA synthesis and manufacturing market's potential lies in the increasing demand for mRNA therapeutics and vaccines, driven by COVID-19 successes. Opportunities include mRNA custom synthesis and ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

A new preclinical study shows that mRNA delivered through lipid nanoparticles can trigger local antibody production in muscle ...

Researchers found that using mental models—visual, verbal, or animated—helps people understand mRNA vaccination science, counter misconceptions, and reduce misinformation spread.

The 5th mRNA-Based Therapeutics Summit Europe is the leading European industry-focused forum dedicated to accelerating the ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional ...

To accurately gauge a vaccine’s risks, it is also crucial to compare its side effects with the effects of the illness it ...

For decades, the flu virus in the shots you’re offered every fall has been grown in chicken eggs. Now, scientists are trying ...

A new approach has been proposed to suppress the side effects of messenger ribonucleic acid (mRNA), opening up possibilities ...